Leach, AdamSmyth, PeterFerguson, LauraSteven, JohnGreene, Michelle K.Branco, Cristina M.McCann, Aidan P.Porter, AndrewBarelle, Caroline JaneScott, Christopher J.2020-07-222020-07-222020-07-21Leach, A, Smyth, P, Ferguson, L, Steven, J, Greene, M K, Branco, C M, McCann, A P, Porter, A, Barelle, C J & Scott, C J 2020, 'Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature', Nanoscale, vol. 12, no. 27, pp. 14751-14763. https://doi.org/10.1039/D0NR02962A2040-3364https://hdl.handle.net/2164/14759Acknowledgements The authors acknowledge the Engineering and Physical Sciences Research Council (EPSRC) (S3802ASA) and the generous support of the Martin Family Foundation for funding the Ph.D. studentships of P. S. and A. L., respectively. This work was also partially funded through a US-Ireland R&D Partnership grant awarded by HSCNI (STL/5010/14), Medical Research Council UK (MC_PC_15013), and the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/R009112/1).133420910engSDG 3 - Good Health and Well-beingR MedicineGeneral Materials ScienceEngineering and Physical Sciences Research Council (EPSRC)S3802ASAMedical Research Council (MRC)MC_PC_15013OtherSTL/5010/14Biotechnology and Biological Sciences Research Council (BBSRC)BB/R009112/1Supplementary DataRJournal article10.1039/D0NR02962Ahttp://www.scopus.com/inward/record.url?scp=85088264245&partnerID=8YFLogxK1227